510(k) Report

510(k) · Cleared

Cleared

Combison 530 Diagnostic Ultrasound Scanner

K940942510(k) TraditionalCleared Feb 19, 19971,086-day reviewClass II21 CFR 892.1560

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medison America, Inc. · IYO System, Imaging, Pulsed Echo, Ultrasonic

Cleared on Feb 19, 1997 after a 1,086-day review. The FDA summary names its predicate without a number. 737 later devices descend from it.

Decided
Feb 19, 1997
Review
1,086 days
Class
Class II
Product code
IYO
Recalls
None
Predicates
0

737 later devices descend from it, 3 citing it directly.

Descendants, by year cleared 1999: 1 descendant cleared2000: 1 descendant cleared2004: 3 descendants cleared2003: 2 descendants cleared2001: 2 descendants cleared2005: 4 descendants cleared2008: 8 descendants cleared2009: 9 descendants cleared2007: 4 descendants cleared2006: 6 descendants cleared2014: 41 descendants cleared2011: 22 descendants cleared2010: 14 descendants cleared2012: 30 descendants cleared2015: 38 descendants cleared2013: 30 descendants cleared2019: 40 descendants cleared2017: 54 descendants cleared2016: 48 descendants cleared2020: 57 descendants cleared2018: 54 descendants cleared2022: 48 descendants cleared2025: 54 descendants cleared2023: 42 descendants cleared2021: 42 descendants cleared2026: 35 descendants cleared2024: 48 descendants cleared1995200020052010201520202025
  1. This deviceK940942 Combison 530 Diagnostic Ultrasound ScannerMedison America, Inc. · 1997
  2. Descendant · cites it directly · 677 of its ownK034003 Hdi 5000 Diagnostic Ultrasound SystemPhilips Ultrasound, Inc. · 2004 · Recalled
  3. Descendant · 2 generations on · 676 of its ownK053069 Sonosite Micromaxx Diagnostic Ultrasound System (C3 Series)Sonosite,Inc. · 2005 · Recalled
  4. Descendant · 3 generations on · 584 of its ownK080935 Sonix MDP Ultrasound ScannerUltrasonix Medical Corporation · 2008
  5. Descendant · 3 generations on · 582 of its ownK083095 Sonixtouch Ultrasound SystemUltrasonix Medical Corporation · 2008
  6. Descendant · 4 generations on · 569 of its ownK092271 GE Logiq E9 BT2010 Diagnostic Ultrasound System, Model 5205000-3…GE Healthcare · 2009 · Recalled

Showing 5 of 737 descendants. See all descendants

Descendants cleared per year

1999: 12000: 12001: 22003: 22004: 32005: 42006: 62007: 42008: 82009: 92010: 142011: 222012: 302013: 302014: 412015: 382016: 482017: 542018: 542019: 402020: 572021: 422022: 482023: 422024: 482025: 542026: 35
1999high 57 (2020) · low 0 (2002)2026

Most influential descendants

Showing 5 of 737 · See all
  • K034003Hdi 5000 Diagnostic Ultrasound SystemPhilips Ultrasound, Inc. · 2004 · cites it directly677descendants
  • K053069Sonosite Micromaxx Diagnostic Ultrasound System (C3 Series)Sonosite,Inc. · 2005 · 2 generations on676descendants
  • K080935Sonix MDP Ultrasound ScannerUltrasonix Medical Corporation · 2008 · 3 generations on584descendants
  • K083095Sonixtouch Ultrasound SystemUltrasonix Medical Corporation · 2008 · 3 generations on582descendants
  • K092271GE Logiq E9 BT2010 Diagnostic Ultrasound System, Model 5205000-3, 5205000-4GE Healthcare · 2009 · 4 generations on569descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K940942Combison 530 Diagnostic Ultrasound ScannerMedison America, Inc.1997—
+1K034003Hdi 5000 Diagnostic Ultrasound SystemPhilips Ultrasound, Inc.20044
+2K053069Sonosite Micromaxx Diagnostic Ultrasound System (C3 Series)Sonosite,Inc.20053
+3K080935Sonix MDP Ultrasound ScannerUltrasonix Medical Corporation2008—
+3K083095Sonixtouch Ultrasound SystemUltrasonix Medical Corporation2008—
+4K092271GE Logiq E9 BT2010 Diagnostic Ultrasound System, Model 5205000-3, 5205000-4GE Healthcare20091

Descendants by year cleared

Year clearedDevicesWith a Class I recall
199910
200010
200120
200320
200430
200540
200660
200740
200880
200990
2010140
2011220
2012300
2013300
2014410
2015380
2016480
2017540
2018540
2019400
2020570
2021420
2022480
2023420
2024480
2025540
2026350
FIG. 1 — Lineage of K940942, 1997–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in IYO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new IYO device

  1. #1 K243937 Accuro 3Sscore 20.5 · 18 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (13)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Kretztechnik Diagnostic Ultrasound Scanner COMBISON 330
Named without a submission number
—
*—Toshiba Diagnostic Ultrasound Scanner SSH-140A
Named without a submission number
—
*—Siemens Diagnostic Ultrasound Scanner SONOLINE SI-450
Named without a submission number
—
*—Kretztechnik Sector Transducer AWP 3.5/A
Named without a submission number
—
*—Kretztechnik Sector Transducer AW 4/5 B/A
Named without a submission number
—
*—Kretztechnik Sector Transducer NW 17.5 B/A
Named without a submission number
—
*—Kretztechnik Transrectal Transducer VRW 177 AK/A
Named without a submission number
—
*—Kretztechnik Transrectal Transducer IRW 177 AK/A
Named without a submission number
—
*—Kretztechnik Transvaginal/Urologic Transducer WIW 17.5 AP/A
Named without a submission number
—
*—Kretztechnik Transvaginal Transducer IR 15/7 BG/A
Named without a submission number
—
*—Acoustic Imaging Convex Sector Transducer CLA 3.5
Named without a submission number
—
*—Acoustic Imaging Convex Sector Transducer CLA 5.0
Named without a submission number
—
*—Acoustic Imaging Linear Array Transducer MLA 7.5
Named without a submission number
—

What descends from it? (737)

See all 737

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K034003Hdi 5000 Diagnostic Ultrasound SystemPhilips Ultrasound, Inc.2004677
K992155Volusion Small Parts Transducer, Model S-VNW 5-10, Volusion Abdominal Transducer, Model…Medison America, Inc.1999208
K002185Sonoace SA 9900 Diagnostic Ultrasound SystemMedison America, Inc.2000207

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K034003 (Philips Ultrasound, Inc., 2004) has gone furthest, with 677 descendants of its own.

How does its category compare?

All IYO devices

IYO System, Imaging, Pulsed Echo, Ultrasonic: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · IYO

7in 2025

2007: 202008: 142009: 132010: 152011: 112012: 152013: 172014: 142015: 192016: 102017: 192018: 142019: 132020: 112021: 152022: 52023: 112024: 102025: 72026 (partial year): 10
2007high 20 (2007) · low 5 (2022)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · IYO

171in 2025

2007: 17 days median2008: 36 days median2009: 79 days median2010: 113 days median2011: 69 days median2012: 68 days median2013: 50 days median2014: 63 days median2015: 46 days median2016: 36 days median2017: 72 days median2018: 56 days median2019: 59 days median2020: 57 days median2021: 64 days median2022: 190 days median2023: 177 days median2024: 220 days median2025: 171 days median2026 (partial year): 139 days median
2007high 220 (2024) · low 17 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · IYO

1in 2022

2007: 42008: 52009: 92010: 82012: 22013: 32014: 22015: 12018: 12019: 12021: 112022: 12026 (partial year): 1
2007high 11 (2021) · low 0 (2011)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · IYO

485in 2025

2007: 392008: 202009: 272010: 202011: 582012: 782013: 4362014: 3042015: 2682016: 2542017: 2382018: 3682019: 5372020: 4982021: 6172022: 5112023: 5272024: 6402025: 485
2007high 640 (2024) · low 20 (2008)2025

MAUDE reports naming product code IYO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072017439
20081436520
20091379927
201015113820
20111169058
20121568278
201317503436
201414632304
201519461268
201610360254
201719720238
201814561368
201913591537
202011570498
2021156411617
202251901511
2023111770527
2024102200640
202571710485
2026101391—

What is it indicated for?

This device is intended for use with the listed transducers for the transcutaneous, transrectal, and transvaginal imaging of organs or structures as an aid in the detection and assessment of physical and functional abnormalities using established diagnostic criteria; and in obstetric patients for the transcutaneous, or transvaginal imaging of the fetus and uterine structures including the performance of fetal measurements for the purpose of assessing…

Read the full statement (919 words)

This device is intended for use with the listed transducers for the transcutaneous, transrectal, and transvaginal imaging of organs or structures as an aid in the detection and assessment of physical and functional abnormalities using established diagnostic criteria; and in obstetric patients for the transcutaneous, or transvaginal imaging of the fetus and uterine structures including the performance of fetal measurements for the purpose of assessing fetal growth and maturity.

This device is intended for use with the COMBISON® 530 system for the transcutaneous imaging of intraabdominal organs and structures including the gastrointestinal tract, kidney, bladder, etc. as an aid in the detection and assessment of physical and functional abnormalities using established diagnostic criteria; and in obstetric patients for the transcutaneous imaging of the fetus and uterine structures including the performance of fetal measurements for the purpose of assessing fetal growth and maturity.

This device is intended for use with the COMBISON® 530 system for the transcutaneous imaging of intraabdominal organs and structures including the gastrointestinal tract, kidney, bladder, etc. as an aid in the detection and assessment of physical and functional abnormalities using established diagnostic criteria; and in obstetric patients for the transcutaneous imaging of the fetus and uterine structures including -the performance of fetal measurements for the purpose of assessing fetal growth and maturity.

This device is intended for use with the COMBISON® 530 system for the transcutaneous imaging of intraabdominal organs and structures including the gastrointestinal tract, kidney, bladder, etc. as an aid in the detection and assessment of physical and functional abnormalities using established diagnostic criteria; and in obstetric patients for the transcutaneous imaging of the fetus and uterine structures including the performance of fetal measurements for the purpose of assessing fetal growth and maturity.

This device is intended for use with the COMBISON* 530 system for the transcutaneous imaging of intraabdominal organs and structures including the gastrointestinal tract, kidney, bladder, etc. as an aid in the detection and assessment of physical and functional abnormalities using established diagnostic criteria; and in obstetric patients for the transcutaneous imaging of the fetus and uterine structures including the performance of fetal measurements for the purpose of assessing fetal growth and maturity.

This device is intended for use with the COMBISON® 530 system for the transcutaneous imaging of intraabdominal organs and structures including the gastrointestinal tract, kidney, bladder, etc. as an aid in the detection and assessment of physical and functional abnormalities using established diagnostic criteria; and in obstetric patients for the transcutaneous imaging of the fetus and uterine structures including the performance of fetal measurements for the purpose of assessing fetal growth and maturity.

This device is intended for use with the COMBISON* 530 system for the transcutaneous imaging of intraabdominal organs and structures including the gastrointestinal tract, kidney, bladder, etc. as an aid in the detection and assessment of physical and functional abnormalities using established diagnostic criteria; and in obstetric patients for the transcutaneous imaging of the fetus and uterine structures including the performance of fetal measurements for the purpose of assessing fetal growth and maturity.

This device is intended for use with the COMBISON* 530 system for the transcutaneous imaging of peripheral vessels and small organs including breast, thyroid, testes, etc. as an aid in the detection and assessment of physical and functional abnormalities using established diagnostic criteria.

This device is intended for use with the COMBISON® 530 system for the transrectal imaging of the rectum and surrounding organs and structures including the rectum wall, prostate gland, etc. as an aid in the detection and assessment of physical and functional abnormalities using established diagnostic criteria. An approved biopsy attachement is available for use with this transducer.

This device is intended for use with the COMBISON* 530 system in the imaging of the fetus and uterine structures utilizing the transvaginal approach as an aid in the diagnosis of obstetrical and gynecological conditions including the performance of fetal measurements for the purpose of assessing fetal growth and maturity. An approved biopsy attachement is available for use with this transducer.

This device is intended for use with the COMBISON* 530 system in the imaging of the fetus and uterine structures utilizing the transvaginal approach as an aid in the diagnosis of obstetrical and gynecological conditions including the performance of fetal measurements for the purpose of assessing fetal growth and maturity. An approved biopsy attachement is available for use with this transducer.

This device is intended for use with the COMBISON* 530 system for the transcutaneous imaging of intraabdominal organs and structures including the gastrointestinal tract, kidney, bladder, etc. as an aid in the detection and assessment of physical and functional abnormalities using established diagnostic criteria; and in obstetric patients for the transcutaneous imaging of the fetus and uterine structures including the performance of fetal measurements for the purpose of assessing fetal growth and maturity.

This device is intended for use with the COMBISON® 530 system for the transcutaneous imaging of intraabdominal organs and structures including the gastrointestinal tract, kidney, bladder, etc. as an aid in the detection and assessment of physical and functional abnormalities using’ established diagnostic criteria; and in obstetric patients for the transcutaneous imaging of the fetus and uterine structures including the performance of fetal measurements for the purpose of assessing fetal growth and maturity.

This device is intended for use with the COMBISON* 530 system for the transcutaneous imaging of peripheral vessels and small organs including breast, thyroid, testes, etc. as an aid in the detection and assessment of physical and functional abnormalities using established diagnostic criteria.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K940942: Combison 530 Diagnostic Ultrasound Scanner.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K940942

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026